tetano
Editor, Senior Moderator
Emerg Infect Dis
. 2020 Dec 21;27(2).
doi: 10.3201/eid2702.201960. Online ahead of print.
Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020
Maryam Shakiba, Maryam Nazemipour, Arsalan Salari, Fardin Mehrabian, Seyed Saeed H Nazari, Seyed Mahmoud Rezvani, Zahra Ghasempour, Abtin Heidarzadeh, Mohammad Ali Mansournia
Abstract
We determined the seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in an affected area in northern Iran in April 2020. Antibodies to SARS-CoV-2 were detected in 528 persons by using rapid tests. Adjusted prevalence of SARS-CoV-2 seropositivity was 22.2% (95% CI 16.4%-28.5%).
Keywords: COVID-19; Guilan; Iran; SARS-CoV-2; asymptomatic infections; coronavirus disease; respiratory infections; seroprevalence; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses.
. 2020 Dec 21;27(2).
doi: 10.3201/eid2702.201960. Online ahead of print.
Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020
Maryam Shakiba, Maryam Nazemipour, Arsalan Salari, Fardin Mehrabian, Seyed Saeed H Nazari, Seyed Mahmoud Rezvani, Zahra Ghasempour, Abtin Heidarzadeh, Mohammad Ali Mansournia
- PMID: 33349310
- DOI: 10.3201/eid2702.201960
Abstract
We determined the seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in an affected area in northern Iran in April 2020. Antibodies to SARS-CoV-2 were detected in 528 persons by using rapid tests. Adjusted prevalence of SARS-CoV-2 seropositivity was 22.2% (95% CI 16.4%-28.5%).
Keywords: COVID-19; Guilan; Iran; SARS-CoV-2; asymptomatic infections; coronavirus disease; respiratory infections; seroprevalence; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses.